Middletown Life

Author: MapLight Therapeutics, Inc.

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

May 1, 2026
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 26, 2026
MapLight Therapeutics to Participate in Upcoming Investor Conferences

March 2, 2026